Skip to main content
OpenTrials

Clinical trial condition

Recurrent Glioblastoma

Explore clinical trials studying Recurrent Glioblastoma. Study availability and eligibility vary by location and protocol.

111 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Glioblastoma trial results

Completed

ASP8374 + Cemiplimab in Recurrent Glioma

NCT04826393

Conditions
Astrocytoma, Glioblastoma, Glioma, +16 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Cincinnati Medical Center Cincinnati, Ohio, United States
  • Hospital of the University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma

NCT04479241

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • UConn Health Farmington, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma

NCT03632135

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • Kaiser Permanente Los Angeles, California, United States
  • Keck School of Medicine of the University of Southern California Los Angeles, California, United States
  • Louisiana State University Health Sciences Center New Orleans, Louisiana, United States
  • Maine Medical Center Research Institute Scarborough, Maine, United States
View all 13 locations
View Trial Details
Completed

A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

NCT02017717

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Local Institution - 0055 Los Angeles, California, United States
  • Local Institution - 0009 Los Angeles, California, United States
View all 112 locations
View Trial Details
Completed

BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations

NCT03914742

Conditions
Astrocytoma, Glioblastoma, Glioma, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

NCT01849146

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details

Related conditions